What’s the secret to aging well? University of Minnesota Medical School researchers have answered it- on a cellular level.
Aging starts in our cells, and those aging cells can hasten cellular senescence, leading to tissue dysfunction and related health impacts.
New research involving University of Minnesota Medical School faculty Paul D. Robbins and Laura J. Niedernhofer, recently published in Nature Medicine, shows there are types of small molecules called senolytics that can reverse the impact of aged, senescent cells.
“We’ve always thought of aging as a process, not a disease,” said Dr. Robbins, Associate Director of the newly founded Institute on the Biology of Aging and Metabolism (iBAM). “But what if we can influence the impacts of aging at a cellular level to promote healthy aging? That’s what senolytics seeks to achieve.”
The research determined whether introducing senescent cells to human and animal tissue would impact the cellular health of surrounding cells. Surprisingly, the transplant of a relatively small number of senescent cells caused persistent physical dysfunction as well as the spread of cellular senescence in previously healthy cells.
In addition, researchers found that a high fat diet, which causes a type of metabolic stress, or simply being old, enhances the physical dysfunction that comes from senescent cells.
“Previous research has shown that our immune system’s ability to eliminate or deal with senescent cells is based 30 percent on genetics and 70 percent on environment,” said Dr. Robbins, noting that what we eat and how often we exercise can affect senescence or aging of cells.
Conversely, the researchers determined that treatment with senolytic drugs, able to eliminate senescent cells, can reverse physical dysfunction and actually extend lifespan even when used in aged animal models.
“We saw greater activity, more endurance, and greater strength following use of senolytics,” said Dr. Robbins.
The paper notes that the results provide proof-of-concept evidence that improved health and lifespan in animals is possible by targeting senescent cells. The hope is that senolytics will prove effective in alleviating physical dysfunction and resulting loss of independence in older adult humans as well.
“This area of research is promising, not just to address the physical decline that comes with aging, but also to enhance the health of cancer survivors treated with radiation or chemotherapy – two treatments that can induce cell senescence,” said Laura Niedernhofer, Director of iBAM.
The Latest on: Senolytic drugs
via Google News
The Latest on: Senolytic drugs
- Chris Reed: Breakthroughs as big as COVID-19 vaccines possible in 2021on March 3, 2021 at 2:41 pm
MIT is going to start building a nuclear fusion reactor this spring — and the excitement among nuclear physicists is palpable.
- Roxithromycin attenuates bleomycin-induced pulmonary fibrosis by targeting senescent cellson March 2, 2021 at 8:49 am
Idiopathic pulmonary fibrosis (IPF) is an aging‐associated disease with a poor prognosis. Emerging evidence has revealed that targeting senescent cells may be a potential treatment for IPF. In this ...
- International journal of biological macromoleculeson February 18, 2021 at 4:00 pm
Chitosan and phospholipid assisted topical fusidic acid drug delivery in burn wound: Strategies to conquer pharmaceutical and clinical challenges, opportunities and future panorama.
- Old age can soon be ‘cured’ scientists believeon February 14, 2021 at 4:50 pm
But Mr Steele thinks its first dividends will emerge within a couple of years, perhaps in the form of senolytic drugs that clear the accumulating cellular detritus of a long life. He makes the ...
- Renal Cancer News and Researchon February 2, 2021 at 4:00 pm
"Senotherapy," a treatment that uses small molecule drugs to target "senescent" cells, or those cells that no longer undergo cell division, blunts liver tumor progression in animal models ...
- Anti-ageing treatments: these two drug types are being investigatedon January 27, 2021 at 5:13 pm
Repurposed drugs One area researchers are investigating is looking at whether any medicines already exist which could tackle ageing. This method is advantageous in that billions of pounds have ...
- UBX.OQ - Unity Biotechnology Inc Profile | Reuterson August 1, 2020 at 9:45 pm
Its lead products candidates include senolytic molecules, UBX0101 and UBX1967, designed for local treatment for the removal of accumulated senescent cells.UBX0101 is a drug candidate developed for ...
- Previous Fundingon August 31, 2019 at 1:04 pm
This project explores the hypothesis that patients with lupus have accelerated accumulation of senescent cells and that treatment with senolytic drugs will clear these cells and improve organ function ...
- Will age soon really just be a number?on May 11, 2019 at 3:52 am
a pioneering academic expert on cellular senescence), Cleara Biotech and Senolytic Therapeutics have developing a class of drugs called "senolytics", which can seek out and destroy worn out cells.
via Bing News